Bank of Montreal’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bank of Montreal’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,200	Closed	-$168K	–	4597
2022 Q1	$168K	Buy	+1,200	New	+$175K	﹤0.01%	3518
2021 Q2	–	Sell	-1,200	Closed	-$662K	–	5350
2021 Q1	$662K	Hold	1,200	–	–	﹤0.01%	2478
2020 Q4	$533K	Hold	1,200	–	–	﹤0.01%	2665
2020 Q3	$295K	Hold	1,200	–	–	﹤0.01%	2558
2020 Q2	$248K	Buy	+1,200	New	+$200K	﹤0.01%	2619
2019 Q1	–	Sell	-5	Closed	-$1K	–	4909
2018 Q4	$1K	Buy	5 +3	+150%	+$460	﹤0.01%	4591
2018 Q3	$0	Hold	2	–	–	﹤0.01%	4958
2018 Q2	$1K	Buy	+2	New	+$1.5K	﹤0.01%	4632
2015 Q3	–	Hold	0	–	–	–	4220
2015 Q2	–	Sell	-3	Closed	-$3.2K	–	4171
2015 Q1	$7K	Hold	3	–	–	﹤0.01%	3572
2014 Q4	$3K	Sell	3 -67	-96%	-$71.6K	﹤0.01%	3792
2014 Q3	$74K	Buy	70 +67	+2,233%	+$113K	﹤0.01%	2971
2014 Q2	$8K	Buy	+3	New	+$6.12K	﹤0.01%	3980

Other funds holding AMPE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's AMPE Position: Q2 2022 in Review

Bank of Montreal sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 1,200 shares — an estimated $168K sold.

Bank of Montreal first reported a position in AMPE in Q2 2014 and held it in 12 quarters. The position peaked at $662K in Q1 2021. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

Bank of Montreal reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
Bank of Montreal sold 1,200 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $168K.
Bank of Montreal first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 12 quarters.
Bank of Montreal's Ampio Pharmaceuticals Inc. position peaked at $662K in Q1 2021.
111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on Bank of Montreal's 13F filing for Q2 2022, filed 11 Aug 2022.